+ -

University of Basel

03 March 2021

Tackling tumors with two types of virus

T cells attack a tumor cell
T cells (grey) attack a tumor cell. Therapeutic cancer vaccines are designed to train immune cells to attack the tumor efficiently. (Symbolic image: royaltystockphoto)

An international research group led by the University of Basel has developed a promising strategy for therapeutic cancer vaccines. Using two different viruses as vehicles, they administered specific tumor components in experiments on mice with cancer in order to stimulate their immune system to attack the tumor. The approach is now being tested in clinical studies.

To top